Cargando…
Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia
B-cell acute lymphoblastic leukemia (B-ALL) is a rare heterogeneous disease characterized by a block in lymphoid differentiation and a rapid clonal expansion of immature, non-functioning B cells. Adult B-ALL patients have a poor prognosis with less than 50% chance of survival after five years and a...
Autores principales: | Boullosa, Laurie Freire, Savaliya, Payalben, Bonney, Stephanie, Orchard, Laurence, Wickenden, Hannah, Lee, Cindy, Smits, Evelien, Banham, Alison H., Mills, Ken I., Orchard, Kim, Guinn, Barbara-Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790505/ https://www.ncbi.nlm.nih.gov/pubmed/29423088 http://dx.doi.org/10.18632/oncotarget.23380 |
Ejemplares similares
-
New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia
por: Jordaens, Stephanie, et al.
Publicado: (2020) -
Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis
por: Brooks, Suzanne E., et al.
Publicado: (2015) -
Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019) -
Identification of Genes Whose Expression Overlaps Age Boundaries and Correlates with Risk Groups in Paediatric and Adult Acute Myeloid Leukaemia
por: Davis, Lindsay, et al.
Publicado: (2020) -
Survivin’ Acute Myeloid Leukaemia—A Personalised Target for inv(16) Patients
por: Greiner, Jochen, et al.
Publicado: (2021)